Association Between DPP-4 Inhibitors and Events of Colorectal and Liver Cancers in Patients With Diabetes Receiving Second-Line Agents: A Nested Case-Control Study

ObjectivePlasma dipeptidyl peptidase-4 (DPP4) levels were significantly lower in patients with colorectal and liver cancers, and animal studies also showed DPP4 inhibitors (DPP4is) have procarcinogenic effects in colorectal cancer. Until now, whether DPP4is therapy affects the progression of liver c...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Chu-Lin Chou, Shu-Hui Juan, Ching-Hao Li, Hsi-Hsien Chen, Chih-Chin Kao, Li-Ying Chen, Li-Nien Chien, Te-Chao Fang
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2022-05-01
Серии:Frontiers in Oncology
Предметы:
DPP-4 inhibitors
colorectal cancer
liver cancer
second-line agents
type 2 diabetes mellitus
Online-ссылка:https://www.frontiersin.org/articles/10.3389/fonc.2022.840142/full
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы